Sydnexis, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2014-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
4
Active:4
Completed:0
Trial Phases
2 Phases
Phase 1:3
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (75.0%)Phase 3
1 (25.0%)The Safety and Efficacy of SYD-101 in Children With Myopia
Phase 3
Active, not recruiting
- Conditions
- Near-sightednessNear SightednessNearsightedness
- Interventions
- Drug: SYD-101 Dose 1Drug: SYD-101 Dose 2Drug: Vehicle
- First Posted Date
- 2019-04-18
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Sydnexis, Inc.
- Target Recruit Count
- 852
- Registration Number
- NCT03918915
- Locations
- 🇺🇸
Site 143, Irwindale, California, United States
🇺🇸Site 144, Pasadena, California, United States
🇺🇸Site 148, San Diego, California, United States
News
No news found